Predictors of response to clozapine

Journal of Clinical Psychiatry

Volumn 55, Issue 9 SUPPL. B, 1994, Pages 126-128

  Lieberman, J A ^a   Kane, J M ^a   Safferman, A Z ^a   Pollack, S ^a   Howard, A ^a   Szymanski, S ^a   Masiar, S J ^a   Kronig, M H ^a   Cooper, T ^a   Novacenko, H ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CLOZAPINE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; AGE FACTORS; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BASAL GANGLIA DISEASES; CLOZAPINE; FEMALE; GROWTH HORMONE; HUMANS; MALE; PROBABILITY; PROLACTIN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; TREATMENT OUTCOME;

EID: 0027959668     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)